Dr Reddys Laboratories is a pharmaceutical company located in India, which is part of the Healthcare sector, and is traded under the ticker RDY on the NYSE exchange.
Dr Reddys Laboratories stock last closed at $54.78, up 0.55% from the previous day, and has decreased 2.56% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.43 percentage points. Dr Reddys Laboratories stock is currently +10.47% from its 52-week low of $49.59, and -6.01% from its 52-week high of $58.28.
At the moment, there are 166.43M RDY shares outstanding. The market value of RDY is $9.12B. In the last 24 hours, 233,162 RDY shares were traded.
How to Buy Dr Reddys Laboratories Stock
Not sure how to invest in Dr Reddys Laboratories stock? Here's how.
Choose where to buy Dr Reddys Laboratories stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you choose where to buy Dr Reddys Laboratories stock.
Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Deposit funds into your brokerage account: Pick your payment method and add your info.
Analyze Dr Reddys Laboratories stock: The Dr Reddys Laboratories ticker symbol is RDY. Is Dr Reddys Laboratories stock a good investment? Should you buy shares of RDY? How do RDY's underlying business fundamentals look? Do top analysts think Dr Reddys Laboratories is a good buy? Why has RDY's stock price moved recently? (Hint: Our stock market research website can help you figure out if RDY is a good stock to buy).
Make your RDY purchase: Decide if you will purchase RDY shares at the current market price or use a limit order to buy RDY stock at a particular price.
Track your investment in RDY: Create a watchlist to watch your investment in Dr Reddys Laboratories shares.
Step 1: Choose where to buy Dr Reddys Laboratories stock
You will need an online brokerage account to access the NYSE market and buy RDY shares.
A brokerage account allows you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to world financial markets: From Technology to Industrials, New York to London — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro now.
After you have figured out the best place to buy Dr Reddys Laboratories stock, it's absolutely critical to research their stock before you invest, so you truly comprehend the risk and opportunity.
Dr Reddys Laboratories Numbers
RDY Price
$54.78
1w %
-0.62%
1y %
-2.56%
5y %
69.49%
P/E
30.23x
P/B
3.75x
P/S
3.33x
PEG
3.81x
Revenue
$2.73B
Earnings
$300.61M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$9.12B
Next Earnings
May 12, 2023
Next Dividend
N/A
Fundamentals of RDY
WallStreetZen was built to help average investors perform better fundamental analysis quickly.
You can see all of the due diligence checks on RDY's stock page.
How is RDY stock valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge RDY's intrinsic value.
Using relative valuations ratios:
RDY could be overvalued based on its P/E ratio of 30.23x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 18.14x
RDY could be overvalued based on its P/B ratio of 3.75x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 1.79x
RDY may be overvalued based on its PEG ratio of 3.81x
There are more short-term assets than short-term liabilities on the RDY balance sheet.
RDY profit margin has gone up from 9.1% to 11% in the past year.
Total RDY debt is lower than 5 years ago, relative to shareholder equity.
There are more short-term assets than long-term liabilities on the RDY balance sheet.
RDY earnings of $424.18M is not sufficient to cover its interest payments.
RDY's operating cash flow of $453.38M allows it to safely service it's debt of $431.70M.
Failed Financial Due Diligence Checks:
RDY has a relatively high debt to equity ratio of 0.54.
Do Wall Street analysts think it's a good time to buy Dr Reddys Laboratories stock
Out of 1 sell side analysts who give forecasts on RDY, the consensus analyst rating on RDY is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
Latest RDY Analyst Forecasts
Balaji Prasad, a bottom 13% analyst from Barclays maintains RDY with a strong buy rating and raises their RDY price target from $66.00 to $67.00, on Oct 31, 2022.
Last year, RDY earnings were $300.61M. In the last five year, RDY's earnings have gone up by 10.9% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 15.79%.
Last year, RDY revenue was $2.73B. Over the last 5 year, RDY's revenue has grown by 5.35% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 19.51%.
Dr Reddys Laboratories pays a dividend of 1.41%, compared to the Drug Manufacturers - Specialty & Generic industry's average dividend yield of 2.39%. If you owned $1,000 worth of RDY stock, you would have received $14.13 last year.
Dr Reddys Laboratories dividend payments have consistently grown over the past decade and have remained stable.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your RDY purchase
There are two primary types of orders:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are generally the easiest way to buy.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at a specific price, place a limit order.
Hit the Open Trade button and your broker will place your order.
If you want additional info about investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Dr Reddys Laboratories share?
As of Mar 24, 2023, it costs $54.78 to buy one share of Dr Reddys Laboratories stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.183 shares of RDY.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.